Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v7.i3.1110
pages 482-483

The HPLC Separation and Bioactivity Evaluation of the Polysaccharopeptide (PSP) of Coriolus (Trametes) versicolor Fermentative Mycelia

Xiao-Tong Yang
Institute of Microbiology and Immunology, Shanghai Normal University; and Department of Pathology, the University of Hong Kong, R.P. China
Yang Qing-Yao
Institute of Microbiology and Immunology, Shanghai Normal University, R.P. China
Mi Ke
Institute of Microbiology and Immunology, Shanghai Normal University, R.P. China
Feng Hui-Qing
Institute of Microbiology and Immunology, Shanghai Normal University, R.P. China
Jones Brain
Department of Pathology, the University of Hong Kong, R.P. China
Jennifer Wan
Department of Zoology, the University of Hong Kong, R.P. China

RÉSUMÉ

Polysaccharopeptide (PSP, commercial name I'm-Yunity™) is isolated from the deep-layer cultivated mycelia of Coriolus versicolor Cov-1™ strain, using patented manufacturing processes. It is a covalently linked protein/polysaccharide complex with a molecular size reported as 100 kD. The polysaccharide moiety consists of 56.1% β-(1, 3) glycan. Its peptide moiety contains 18 kinds of amino acids in which the glutamic acid and aspartic acid are the most abundant.
The pharmacological study and clinical trials have proved that PSP possesses immunomodulatory effects that can benefit cancer patients by improving their immunity and life quality. It also can antagonize the side-effects caused by radio- or chemotherapy.
Previous studies have shown that PSP has several fractions. Electrophoresis results showed that PSP had three bands, and similar results were obtained using column chromatography. Yang MMP and colleagues separated PSP into two fractions by using reverse phase HPLC and detected the first eluant possessing direct antitumor activity. However, the contributions of all PSP fractions to its bioactivities are still not well understood. Therefore, in this study, we applied an anion ion-exchange HPLC method to separate PSP and evaluated the bioactivity of its fractions.
The commercial PSP product was dissolved in 95 °C water and centrifuged to remove auxiliary materials and precipitants. It was further desalted and freeze-dried prior to HPLC separation. The freeze-dried powder was dissolved in an initial buffer and injected into a preparative anion ion-exchange HPLC column. The column was eluted with initial buffer following an increased NaCl gradient. After that, PSP was separated into four fractions: Fr1, without a negative charge; Fr2, with a weak negative charge; Fr3, with a moderate negative charge; and Fr4 with a strong negative charge. Chemical analysis reveals that the polysaccharide content of Fr2 is the highest (92.5%), while the Fr4 is the lowest (35.2%). However, the β-(1,3) glucan contents in polysaccharides are reversed, and the Fr4 has the highest content (51.0%), while Fr1 and Fr2 have almost no β-(1, 3) glucan detected. Fr1 and Fr2 also have roughly half-protein contents compared to Fr4 and Fr3, and the highest content is in Fr3 (22.6%).
The mouse splenocyte proliferation assay reveals that the Fr4 and Fr3 have stronger immuno-stimulatory effects than Fr2 and Frl.The stimulatory index of Fr4, Fr3, Fr2, and Fr1 are 1.29, 1.27, 1.12, and 1.08, respectively. Fr3 and Fr4 also elevate mouse splenocyte CD4+/CD8+ ratio, while Fr1 and 2 retained or slightly decreased compared to unfraction-ized PSP. All four fractions strongly stimulate the production of IL-6 and TNF-α from human PBMN cells.The IL-6 production was increased up to around 8.1 fold by Fr 2 and 4, and TNF-α level was even heightened to 12.7 folds by Fr2 and Fr3.
In conclusion, PSP probably contains several compounds, and these compounds can be fraction-ized using an anion ion-exchange HPLC method. Different fractions showed diverse pharmacological activities as well as different physical and chemical properties. To understand the relation of PSP fractions to their bioactivities, it may help us to set up specific quality control methods to monitor and to improve PSP quality and to develop the product with higher efficacy.


Articles with similar content:

Submerged and Solid-State Cultivation of Bioactive Extra- and Intracellular Polysaccharides of Medicinal Mushrooms Ganoderma lucidum (W. Curt.: Fr.) P. Karst. and Grifola frondosa (Dicks.: Fr.) S. F. Gray (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.11, 2009, issue 4
Branka Wraber, Jozica Habijanic, Mirjan Svagelj, Bojana Boh, Marin Berovic
Studies on Antioxidant Effects of Culinary-Medicinal Bunashimeji Mushroom Hypsizygus marmoreus (Peck) Bigel. (Agaricomycetideae)
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 3
Tsunetomo Matsuzawa
Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) Inhibits Proliferation of Human Peripheral Blood Lymphocytes by Blocking lnterleukin-2 Secretion
International Journal of Medicinal Mushrooms, Vol.2, 2000, issue 4
Ha Won Kim, Byong Kak Kim, Mi Ja Shim
Comparison of the Immunomodulating Activities of 1,3-β-glucan Fractions from the Culinary-Medicinal Mushroom Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 3
Yoshiyuki Adachi, Noriko N. Miura, Hiromi Kawaminami, Toshiro Yadomae, Mitsuhiro Nakajima, Naohito Ohno, Toshie Harada
Immunomodulation and Antitumor Activity of a Mushroom Product, Proflamin, Isolated from Flammulina velutipes (W. Curt.: Fr.) Singer (Agaricomycetideae)
International Journal of Medicinal Mushrooms, Vol.9, 2007, issue 2
Tetsuro Ikekawa, Hirofumi Maruyama